Anatara Lifesciences Limited, based in Carlton, Australia, is a research and development company that focuses on evidence-based solutions for gastrointestinal diseases in both humans and animals. Its flagship product, Gastrointestinal ReProgramming (GaRP), is a proprietary formulation that targets primary underlying factors related to gastrointestinal conditions such as irritable bowel syndrome and inflammatory bowel disease. Additionally, the company has developed Detach, a treatment for diarrhea in piglets, and is working on bromelain-based formulations for piglets and poultry. Anatara Lifesciences Limited was founded in 2010.